Platelet Activation and Aggregation Promote Lung Inflammation and Influenza Virus Pathogenesis
Platelet Activation and Aggregation Promote Lung Inflammation and Influenza Virus Pathogenesis
复制标题
DOI:
10.1164/rccm.201406-1031oc
复制
发表时间:
2015-04-01
影响因子:
24.7
通讯作者:
Riteau, Beatrice
中科院分区:
文献类型:
--
作者:
Vuong Ba Le;Schneider, Jochen G.;Riteau, Beatrice
Rationale: The hallmark of Severe influenza virus infection is excessive inflammation of the lungs. Platelets are activated during influenza, but their role in influenza virus pathogenesis and inflammatory responses is unknown.Objectives: To determine the role of platelets during influenza A virus infections and propose new therapeutics against influenza.Methods: We used targeted gene deletion approaches and pharmacologic interventions to investigate the role of platelets during influenza virus infection in mice.Measurements and Main Results: Lungs of infected mice were Massively infiltrated by aggregates of activated platelets. Platelet activation promoted influenza A virus pathogenesis. Activating protease-activated receptor 4, a platelet receptor for thrombin that is crucial for platelet activation, exacerbated influenza-induced acute lung injury and death. In contrast, deficiency in the major platelet receptor glycoprotein IIIa protected mice from death caused by influenza viruses, and treating the mice with a specific glycoprotein IIb/IIIa antagonist, eptifibatide, had the same effect. Interestingly, mice treated with other antiplatelet compounds (antagonists of protease-activated receptor 4, MRS 2179, and clopidogrel) were also protected from severe lung injury and lethal infections induced by several influenza strains.Conclusions: The intricate relationship between hemostasis and inflammation has major consequences in influenza virus pathogenesis, and antiplatelet drugs might be explored to develop new antiinflammatory treatment against influenza virus infections.